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Abstract
Study objectives: Mechanical ventilation (MV) is a life-support measure for patients who cannot maintain 
adequate alveolar ventilation. Following prolonged MV, difficulty in weaning patients from the ventilator can 
occur, and it has been postulated that difficult weaning is linked to respiratory muscle dysfunction. We tested the 
hypothesis that 18 h of controlled MV will diminish diaphragmatic maximal tetanic specific tension (force per 
cross-sectional area of muscle) without impairing diaphragmatic fatigue resistance. 
Design: To test this postulate, adult Sprague-Dawley rats were randomly classified into one of two experimental 
groups: (1) control group (n = 8), and (2) 18-h  MV group (n = 6).  MV-treated animals were anesthetized, 
tracheostomized, and received room air ventilation. Animals in the control group were acutely anesthetized but 
did not receive MV. Muscle strips from the mid-costal diaphragm were removed from both experimental groups, 
and contractile properties were studied in vitro to determine the effects of MV on diaphragmatic endurance and 
maximal force production. Diaphragmatic endurance was investigated by measuring tension development during 
repeated contractions throughout a 30-min fatigue protocol. 
Results: MV resulted in a reduction (p 0.05) in diaphragmatic maximal specific tension (control group, 26.8 ± 0.2 
Newtons/cm2 vs MV group, 21.3 ± 0.6 Newtons/cm2). Compared to the control group, diaphragms from MV-
treated animals maintained higher (p 0.05) percentages of the initial force production throughout the fatigue 
protocol. The observed improvement in fatigue resistance was associated with an increase in diaphragmatic 
oxidative and antioxidant capacity as evidenced by increases (p 0.05) in both citrate synthase and superoxide 
dismutase activities. However, by comparison to the control group, diaphragms from MV-treated animals 
generated less (p 0.05) absolute specific force throughout the fatigue protocol. 
Conclusions: These data indicate that 18 h of MV enhances diaphragmatic fatigue resistance but impairs 
diaphragmatic specific tension.  
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Study objectives: Mechanical ventilation (MV) is a life-support measure for patients who cannot 
maintain adequate alveolar ventilation. Following prolonged MV, difficulty in weaning patients 
from the ventilator can occur, and it has been postulated that difficult weaning is linked to 
respiratory muscle dysfunction. We tested the hypothesis that 18 h of controlled MV will diminish 
diaphragmatic maximal tetanic specific tension (force per cross-sectional area of muscle) without 
impairing diaphragmatic fatigue resistance. 
Design: To test this postulate, adult Sprague-Dawley rats were randomly classified into one of two 
experimental groups: (1) control group (n = 8), and (2) 18-h  MV group (n = 6).  MV-treated 
animals were anesthetized, tracheostomized, and received room air ventilation. Animals in the 
control group were acutely anesthetized but did not receive MV. Muscle strips from the mid-
costal diaphragm were removed from both experimental groups, and contractile properties were 
studied in vitro to determine the effects of MV on diaphragmatic endurance and maximal force 
production. Diaphragmatic endurance was investigated by measuring tension development 
during repeated contractions throughout a 30-min fatigue protocol. 
Results: MV resulted in a reduction (p 0.05) in diaphragmatic maximal specific tension (control 
group, 26.8 ± 0.2 Newtons/cm2 vs MV group, 21.3 ± 0.6 Newtons/cm2). Compared to the control 
group, diaphragms from MV-treated animals maintained higher (p 0.05) percentages of the 
initial force production throughout the fatigue protocol. The observed improvement in fatigue 
resistance was associated with an increase in diaphragmatic oxidative and antioxidant capacity as 
evidenced by increases (p 0.05) in both citrate synthase and superoxide dismutase activities. 
However, by comparison to the control group, diaphragms from MV-treated animals generated 
less (p 0.05) absolute specific force throughout the fatigue protocol. 
Conclusions: These data indicate that 18 h of MV enhances diaphragmatic fatigue resistance but 
impairs diaphragmatic specific tension.  
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Abbreviations: CS = citrate synthase; Cu-Zn-SOD = copper zinc-superoxide dismutase; LDH = lactate dehydroge- 
nase; Lo = optimal contractile length; Mn-SOD = manganese-superoxide dismutase; MV = mechanical ventilation; 
specific Po = maximal force production per cross-sectional area of muscle; SOD = superoxide dismutase 
echanical  ventilation  (MV)  is  critical  for  life
support in patients who cannot maintain ade- 
quate  alveolar  ventilation.  Clinical -applications  of 
MV include respiratory failure, neuromuscular dis- 
eases,  drug  overdoses,  and  recovery  from  general 
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anesthetics.1 Unfortunately, following prolonged 
MV, difficulty in weaning patients from the 
ventilator occurs in many cases.2– 4 It has been 
postulated that difficult weaning is often due to 
respiratory muscle dysfunction due to 
diaphragmatic force deficits (ie, reduced maximal 
force production) and/or decreased diaphragmatic 
fatigue resistance.2–5 
To date, only three published reports have investi- 
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gated the affects of prolonged MV on diaphragm 
maximal force production in animals. The findings of 
these studies are consistent and indicate that MV is 
associated with a significant decrement in 
diaphragmatic total force generation and maximal 
tetanic force production per cross-sectional area of 
muscle (specific Po). For example, recent animal 
experiments in our laboratory reveal that as little as 
12 h of MV results in a depression in diaphragmatic 
specific Po, and this force deficit is exacerbated with 
time on the ventilator.6 These findings are corroborated 
by other studies7,8 that indicate prolonged MV is 
associated with a diaphragmatic force deficit. 
Collectively, these results are consistent with the notion 
that diaphragmatic force deficits may contribute to 
difficult weaning. 
While it is clear that prolonged MV results in a 
diaphragmatic force deficit, it is unknown if rela- 
tively short durations of MV impair diaphragmatic 
endurance. At present, only one experiment has 
investigated the effects of prolonged MV on dia- 
phragmatic fatigue resistance. Anzueto et al7 re- 
ported that 11 days of controlled MV in baboons 
resulted in impaired diaphragmatic endurance as 
indicated by a decline in transdiaphragmatic force 
production during repeated stimulation of the 
phrenic nerves. Although this experiment suggests 
that prolonged MV diminishes diaphragmatic endur- 
ance, several unanswered questions remain. For 
example, in the experiments of Anzueto et al,7 a 
reduction in transdiaphragmatic pressure during 
phrenic stimulation could occur due to failure within 
peripheral nerves and/or the diaphragm. It remains 
unknown if MV promotes alterations in the dia- 
phragm that result in diminished endurance. Fur- 
thermore, while long-term (eg, 11 days) MV impairs 
diaphragmatic endurance, it is unknown whether 
relatively short-duration MV (eg, < 24 h) would also 
impair diaphragmatic endurance. Hence, these un- 
answered questions form the rationale for the cur- 
rent experiments. Therefore, we examined the ef- 
fects of relatively short-duration MV on both 
diaphragmatic fatigue and specific Po. To separate 
central fatigue from peripheral fatigue, we investi- 
gated diaphragm contractile function in vitro using 
direct (electrical) stimulation of the muscle. Based 
on preliminary experiments in our laboratory, we 
hypothesized that 18 h of MV impairs diaphragmatic 
specific Po but does not accelerate the rate of 
diaphragmatic fatigue development. 
Materials and Methods 
Experimental Animals and Research Design 
These experiments were approved by the University of Florida 
animal use committee, and followed the guidelines for animal 
experiments established by the National Institutes of Health. 
Healthy, female, young adult (4-month-old) Sprague-Dawley rats 
were individually housed, fed rat chow and water ad libitum, and 
were maintained on a 12-h light/dark cycle for 3 weeks prior to 
initiation of these experiments. Animals were randomly assigned 
to one of two experimental groups: control animals (n = 8) or 
MV-treated animals (n = 6). 
Protocol for Control Animals: The animals in the control group 
were free of intervention prior to measurement of diaphragmatic 
contractile properties. That is, these animals did not receive 
mechanical ventilation or long-term anesthesia prior to study. At 
the specified time, animals in the control group received an 
intraperitoneal injection of sodium pentobarbital (50 mg/kg body 
weight). After a surgical plane of anesthesia was achieved, the 
diaphragm was rapidly removed for measurement of in vitro 
contractile properties. 
Protocol for MV-Treated Animals: All surgical procedures were 
performed using aseptic technique. Animals randomly selected 
for MV were anesthetized with an intraperitoneal injection of 
sodium pentobarbital (50 mg/kg body weight). After reaching a 
surgical plane of anesthesia, the animals were tracheostomized 
and placed on MV using a volume-driven, small-animal ventilator 
(model CIV-101; Columbus Instruments; Columbus, OH). All 
breaths were delivered by the ventilator; hence, this mode of 
ventilation (ie, controlled MV) results in complete diaphragmatic 
inactivity. The tidal volume was established at approximately 1 
mL/100 g of body weight with a respiratory rate of 80 breaths/ 
min. Additionally, positive end-expiratory pressure of 1 cm H2O 
was used throughout the protocol. Previous experiments in our 
laboratory indicate that this MV protocol results in arterial blood 
gas and pH homeostasis during a 24-h period.6 
A venous catheter was placed in the jugular vein to permit the 
infusion of isotonic saline solution and sodium pentobarbital 
when necessary. Anesthesia was maintained over the entire 
period of MV by infusing sodium pentobarbital (10 mg/kg body 
weight/h). Body temperature was maintained at approximately 
37°C by use of a recirculating heating blanket. Additionally, heart 
rate and electrical activity of the heart were monitored via a lead 
II ECG using needle electrodes placed subcutaneously. 
Throughout MV, animals received enteral nutrition using the 
American Institute of Nutrition-76 rodent diet (Research Diets; 
New Brunswick, NJ). Furthermore, body fluid homeostasis was 
maintained via the administration of 2.0 mL/kg/h IV electrolyte 
solution. 
Continuing care during MV included expressing the bladder, 
removing airway mucus, lubricating the eyes, rotating the animal, 
and passive movement of the limbs. This care was maintained 
throughout the experimental period at 2-h intervals. On comple- 
tion of MV, one segment of the costal diaphragm was removed 
for measurement of in vitro contractile properties and another 
segment was dissected, frozen in liquid nitrogen, and stored at 
- 80°C until subsequent assay. 
Measurement of In Vitro Diaphragmatic Contractile Properties 
Description of the Muscle Organ Bath: Details of our in vitro 
protocol have been described in detail elsewhere,9 –11 and will be 
briefly described here. After reaching a surgical plane of anes- 
thesia, the entire diaphragm was removed and placed in a 
dissecting chamber containing a Krebs-Hensleit solution equili- 
brated with a 95% O2/5% CO2 gas. A muscle strip, including the 
tendenous attachments at the central tendon and rib cage 
(dimensions, 20 ± 3 mm), was dissected from the midcostal 
region. The strip was suspended vertically between two light- 
weight Plexiglas clamps with one end connected to an isometric 
force transducer (model FT-03; Grass Instruments; Quincy, MA) 
within a jacketed tissue bath. The force output was recorded via 
a computerized data-acquisition system (Super Scope II; GW 
Instruments; Somerville, MA; Apple Computer; Cupertino, CA). 
The tissue bath was filled with Krebs-Hensleit saline solution and 
12 µ,M d-tubocurarine to produce complete neuromuscular 
blockade. The saline solution within the bath was aerated with gas 
(95% O2/5% CO2), pH was maintained at 7.4, and the osmolality 
of the bath was approximately 290 mOsmol. 
Determination of the Optimal Length/Tension Relationship: 
Following a 15-min equilibration period (25°C), in vitro 
diaphragmatic contractile measurements were made. The 
muscle strip was stimulated along its entire length with 
platinum wire electrodes (modified S48 stimulator; Grass 
Instruments) using supramaximal (approximately 150%) 
stimulation voltage. Opti- mum contractile length (Lo) was 
determined by systematically adjusting the length of the 
muscle using a micrometer while evoking single twitches. 
Thereafter, all contractile properties were measured 
isometrically at Lo. 
Peak Twitch and Tetanic Tension: After finding Lo, the bath 
temperature was increased to 37°C; following a 30-min 
equilibration period, peak twitch tension was determined using 
supra- maximal monophasic pulses of 2 ms. Peak isometric 
twitch tension was determined from a series of three single 
pulses. Maximal isometric tetanic contractions were then 
produced using a supramaximal stimulus train of 500-ms 
duration (160 Hz). Force was monitored by the 
computerized system described above. Peak isometric tetanic 
tension was measured from a series of three contractions with a 
3-min recovery between measurements. 
Fatigue Tolerance: Five minutes after completion of the last 
peak tetanic tension measurement, the diaphragm strip was 
subjected to a 30-min fatigue protocol. To test fatigue resistance, 
the strip was stimulated submaximally at 2-s intervals (30 Hz; 
250-ms train duration) for 30 min. Tolerance to fatigue (fatigue 
index) was assessed by the percentage of initial force generated 
by the strip compared to the tension developed at various time 
intervals during the protocol. 
After completion of the contractile measurements, Lo was 
measured and the diaphragm muscle strip was weighed. Muscle 
cross-sectional area was determined using the method described 
by Close,12 and this calculation was used to normalize muscle 
force production to the cross-sectional area of the muscle (ie, 
specific Po). 
Biochemical Measurements 
To determine the effects of MV on both bioenergetic and 
antioxidant enzymes, we measured the activities of citrate syn- 
thase (CS), lactate dehydrogenase (LDH), and superoxide dis- 
mutase (SOD). CS is a Krebs cycle enzyme and is considered to 
be a standard marker of the oxidative capacity of a tissue since it 
is highly correlated with mitochondrial respiratory capacity.13 
LDH is a glycolytic enzyme and is highly correlated with maximal 
glycolytic flux.13 SOD scavenges superoxide radicals and is 
considered to be one of the most important enzymes in the 
antioxidant defense system.14 SOD exists in two isoforms in 
muscle fibers: copper zinc-SOD [CU-Zn-SOD], and manganese- 
SOD [Mn-SOD]. Cu-Zn-SOD is located in the cytosol, whereas 
Mn-SOD is found primarily in mitochondria. To determine 
muscle enzyme activities, muscle samples were homogenized in 
cold 100-mM phosphate buffer with 0.05% bovine serum albu- 
min (1:20 weight/volume; pH 7.4). Homogenates were then 
centrifuged at 4°C for 10 min at 400g. The resulting supernatant 
was decanted and assayed for enzyme activity and protein 
content. CS, LDH, and SOD activities were measured using 
techniques described by Srere,15 Passonneau and Lowry,16 and 
Quick et al,17 respectively. Protein concentration was determined 
using techniques described by Bradford.18 
Postmortem Examination 
To determine if our animals acquired an infection during our 
experiments, three separate blood samples were removed, 
smeared on microscope slides, and stained using a bacteriologic 
stain (Gram stain; Sigma Chemical Company; St. Louis, MO); 
each sample was then microscopically examined for the presence 
of bacteria. Furthermore, lungs were visually examined for 
abnormalities. If macroscopic abnormalities of the lung were 
observed during necropsy, these animals were eliminated from 
the study. 
Statistical Analysis 
Comparisons between groups for each dependent variable 
measured were made. Isometric contractile parameters and 
biochemical measurements were analyzed with an unpaired t 
test, and where significant differences existed a Scheffe test was 
used post hoc. The fatigue data were analyzed by a two-way 
analysis of variance with repeated measures across time and 
analyzed post hoc with a Bonferroni-corrected t test. Significance 
was established at p < 0.05. 
Results 
Systemic and Biological Response to MV 
No animals were eliminated due to infection. 
However, one animal from the MV group was 
eliminated from our analysis because the 
postmortem examination revealed evidence of 
lung barotrauma. Of the animals included in 
our analysis, initial and final body  weights  did 
not  differ (p > 0.05) between control animals and 
MV-treated animals. Importantly, 18 h of MV did 
not result in a significant change (p > 0.05) in 
animal body weight (data not shown). These 
results indicate that our schedule of nutrition and 
rehydration was adequate. Also, animals in the MV-
treated group urinated and experienced intestinal 
transit throughout the experimental period. 
Since sepsis promotes diaphragmatic contractile 
dysfunction, strict aseptic techniques were followed 
throughout the experiments. Importantly, our results 
indicate that the MV-treated animals did not acquire 
infections during MV. For example, microscopic 
examination of blood revealed no detectable 
bacteria, and postmortem examination of the lungs 
(visual) and peritoneal cavity (visual) displayed no 
detectable abnormalities. Furthermore, our MV-
treated animals were afebrile during the 
investigation, with body temperatures ranging 
from 36.5 to 37.6°C; and, as noted above, no 
significant (p > 0.05) changes occurred in the 
body weights of our MV-treated animals. 
Collectively, these results indicate that the MV-
treated animals used in our analysis were free of 
significant  infection. 
MV and Diaphragmatic Contractile Properties 
Lo ranged from 1.9 to 2.1 cm across all diaphragm 
strips  investigated,  and  no  differences  existed 
Table 1—Maximal Isometric Twitch and Tetanic Force Production in Diaphragm Strips Obtained From Control 
Animals or MV-Treated Animals* 
Experimental Groups 
Maximal Isometric Twitch 
Force,  Newtons/cm2
Maximal Isometric Tetanic 
Force,  Newtons/cm2
Twitch/Tetanic 
Force Ratio 
Control animals 5.3 ± 0.2 26.8 ± 0.2 0.20 ± 0.01 
MV-treated  animals 3.7 ± 0.2† 21.3 ± 0.6† 0.18 ± 0.01 
*Data are presented as mean ± SEM.
†Different from control at p < 0.05. 
(p > 0.05) in Lo between the control group and the 
MV group. MV resulted in a significant (p < 0.05) 
reduction in both diaphragmatic maximal twitch 
force production and specific Po (Table 1). In 
contrast, no group differences (p > 0.05) existed in 
the twitch/tetanic force production ratio (Table 1). 
Figure 1 illustrates the change in the percentage 
of initial force production during the 30-min fatigue 
protocol. Compared to control animals, diaphragms 
from MV-treated animals maintained a significantly 
greater (p < 0.05) fatigue index (ie, higher relative 
forces) throughout the fatigue test. In contrast, when 
diaphragmatic force production during the fatigue 
test is compared by the absolute specific force 
produced, diaphragms from control animals 
produced higher (p < 0.05) specific forces than 
diaphragms from MV-treated animals throughout 
the 30-min fatigue protocol (Fig 2). 
Biochemical Measurements 
Activities for CS, LDH, and SOD are contained in 
Table 2. Compared to MV-treated animals, LDH 
activities tended to be higher in diaphragms from 
control animals but these differences were not sig- 
nificant. In contrast, costal diaphragm CS, total 
SOD, Cu-Zn-SOD, and Mn-SOD activities were 
significantly higher in MV-treated animals compared 
to control animals. Our finding that MV elevates 
diaphragmatic CS differs from a previous report 
indicating that 48 h of MV does not alter diaphrag- 
matic oxidative capacity.8 The explanation for these 
divergent findings is not clear. 
Discussion 
Overview of Principle Findings 
Although previous experiments have reported that 
relatively short-duration MV results in diaphragmatic 
force deficits, the present experiments provide 
important new information regarding the influence 
of controlled MV on diaphragmatic endurance. 
Our results support the hypothesis that 18 h of 
MV results in a significant reduction 
(approximately 20%) in diaphragmatic specific 
Po. Furthermore, these data support the notion 
that 18 h of MV does not accelerate the rate of 
diaphragmatic fatigue development. In fact, our 
findings indicate that 18 h 
Figure 1. Comparison of the loss of relative force production of 
the diaphragm during the 30-min fatigue test in both control and 
MV-treated animals. Values are means ± SEM. *Group 
differences at p < 0.05. 
Figure 2. Comparison of diaphragmatic specific force 
production between control animals and the MV-treated 
animals. Values are means ± SEM  *Group  differences  at  
p < 0.05. N = Newton. 
Table 2—CS, LDH, and SOD Activities in the Costal Diaphragm of Control Animals and MV-Treated Animals* 
Groups CS Activity† LDH Activity† Total SOD‡ Cu-Zn-SOD‡ Mn-SOD‡ 
Control animals 0.21 ± 0.01 2.5 ± 0.1 29.5 ± 0.2 11.2 ± 0.2 18.3 ± 0.2 
MV-treated  animals 0.33 ± 0.02§ 2.2 ± 0.3 37.2 ± 0.3§ 13.4 ± 0.2§ 23.4 ± 0.2§ 
*Data are presented as mean ± SEM.
†Expressed as micromoles of substrate converted per minute per milligram of protein. 
‡Expressed as units per milligram of protein. 
§Different from control at p < 0.05. 
of MV improves diaphragmatic fatigue resistance as 
evidenced by the higher fatigue index in diaphragms 
of MV-treated animals compared to control animals 
(Fig 1). A detailed analysis of our experimental 
model and these findings follows. 
Analysis of Experimental Model 
We choose an animal model to investigate the 
effects of MV on the diaphragm due to the invasive 
nature of obtaining a diaphragmatic biopsy from 
human subjects. Our considerations in the choice of 
an animal model included both pragmatic issues (ie, 
animal size and cost) and the applicability of the 
animal model to humans. In regard to pragmatic 
issues, the rat is a relatively inexpensive model to 
study the effects of MV, and does not pose technical 
difficulties during tracheostomy and enteral feeding. 
In reference to applicability to humans, the rat is an 
excellent model to investigate diaphragmatic issues 
since human and rat diaphragms are similar in 
muscle fiber type, gross anatomic features, and 
function.13,19 
To investigate the effects of prolonged MV on 
diaphragmatic contractile function, we chose to use 
controlled MV for two principal reasons. Firstly, 
compared to assist modes of MV, an advantage of 
controlled MV is that this mode results in rapid 
diaphragmatic atrophy.20 This is experimentally 
advantageous because it permits the study of 
the adverse effects of MV on the diaphragm 
following relatively short periods of MV. 
Secondly, although many patients receiving MV 
have some form of pressure-assist ventilation, 
controlled MV has clinical relevance because this 
mode of ventilation is used in adult patients in 
several circumstances (eg, drug overdose, spinal 
cord injury, surgery, etc).1 Further- more, 
controlled MV is also used widely in pediatric 
situations.1 
We selected sodium pentobarbital as the general 
anesthetic in these experiments because this anes- 
thetic, when used in low doses, does not negatively 
impact locomotor and diaphragm contractile func- 
tion. For example, work by Le Bourdelles et al8 
reveals that the level of sodium pentobarbital re- 
quired to maintain a surgical plane of anesthesia in 
rats over a 48-h period does not promote locomotor 
muscle atrophy nor does it impair locomotor muscle 
maximal tetanic force production. Furthermore, re- 
cent experiments in our laboratory with 
anesthetized, spontaneously breathing animals 
clearly reveals that the level of sodium 
pentobarbital required to maintain a surgical plane 
of anesthesia does not impair diaphragm 
contractile function following 24 h of anesthesia.6
Prolonged MV and Diaphragmatic Force Deficits 
The current experiments support previous re- 
ports6 – 8 that prolonged MV results in a significant 
reduction in both twitch and maximal diaphragmatic 
specific Po. There are at least four possible 
explanations for the diaphragmatic force deficit 
associated with prolonged MV. These include 
the negative impact of anesthesia on muscle 
function, infection, arterial pH imbalance, and/or 
intrinsic alterations in diaphragm muscle fibers.21–24
Previous experiments in our laboratory indicate 
that the MV-induced diaphragmatic contractile 
dysfunction is not due to anesthesia, infection, or a 
pH/blood gas disturbance.6 Therefore, we have 
concluded that the MV-induced contractile 
dysfunction is due to intrinsic changes within 
diaphragmatic muscle fibers6 that could 
theoretically stem from one or several different 
mechanisms. Specifically, a reduction in 
myofibrillar protein concentration, abnormalities 
of contractile/ cytoskeletal proteins, and/or 
impaired excitation contraction-coupling could 
individually or collectively contribute to the 
observed force deficit.9,10,24,25 Which of these 
factors is responsible for the observed force 
deficit is unknown and warrants further study. 
Moderate-Duration MV Improves Diaphragmatic 
Fatigue Resistance 
Our results indicate that 18 h of MV improves 
diaphragmatic resistance to fatigue (Fig 1). At least 
four different physiologic mechanisms could explain 
this observation. First, MV is associated with an 
increase in diaphragmatic oxidative capacity. This 
prospect was supported by our experimental findings 
that CS activity (Krebs cycle enzyme and a marker of 
oxidative capacity) in the diaphragm was significantly 
higher in MV-treated animals compared to control 
animals (Table 2). This group difference in 
diaphragmatic CS activity is likely related to the 
pattern of muscle fiber atrophy during MV. A 
previous study in our laboratory indicates that 
while MV results in atrophy of all fiber types 
within the diaphragm, compared to type I 
fibers, the magnitude of MV- induced atrophy 
was greatest in type IIx and type IIb fibers.20 In our 
previous study, the relative contribution of these 
type II fibers to the total cross-sectional area of the 
diaphragm was approximately 53% in the control 
animals and was reduced to approximately 46% in 
the MV-treated animals. This is significant 
because type IIx and type IIb fibers possess the 
lowest oxidative capacity and are therefore the most 
fatigable motor units in the diaphragm. Hence, a 
selective atrophy of type IIx and type IIb fibers 
would reduce the relative rate of fatigue in dia- 
phragms from MV-treated animals.26 We postulate 
that this explanation accounts for a significant por- 
tion of the MV-induced improvement in diaphrag- 
matic fatigue resistance. Similar conclusions have 
been reached by others investigating the effects of 
malnutrition on diaphragmatic fatigue.26
A second explanation for the improved diaphrag- 
matic fatigue resistance associated with MV is the 
finding that diaphragms from MV-treated animals 
possessed elevated SOD activities. This is significant 
because SOD scavenges superoxide radicals and is 
considered to be one of the most important enzymes 
in the antioxidant defense system.14 Furthermore, it 
is noteworthy that the activities of both intracellular 
isoforms of SOD (ie, Cu-Zn-SOD and Mn-SOD) 
were elevated in diaphragms from MV-treated 
animals. This observation indicates that MV is 
associated with improved superoxide scavenging 
capacity in both the cytosol and mitochondria. The 
biological importance of an elevated antioxidant 
capacity is that contraction-induced radical 
production and oxidative stress in the diaphragm 
is a contributory factor to diaphragmatic fatigue.27–
29 Hence, improved antioxidant capacity in the 
diaphragms of MV-treated animals could 
counteract contraction-induced oxidant stress and 
improve diaphragmatic fatigue resistance. 
A third potential explanation for the enhanced 
fatigue resistance of diaphragms from MV-treated 
animals relates to the fact that MV-induced atrophy 
is associated with a reduction in muscle fiber cross- 
sectional area.20 This reduction in fiber cross- 
sectional area reduces the distances for substrate 
diffusion within muscle fibers. Hence, this atrophy- 
related decrease in diffusion distances for energy 
substrates could facilitate substrate utilization and 
energy production.26 Nonetheless, at present, it is 
unknown if diaphragmatic atrophy alone will im- 
prove fatigue resistance. 
A final possible explanation for the enhanced 
fatigue resistance of diaphragms from MV-treated 
animals relates to the observation that MV is 
associated with a reduction in diaphragmatic force 
production per cross-sectional area of the fiber (ie, 
reduced specific force production). This 
observation suggests that adenosine triphosphate 
utilization would be reduced in diaphragms from 
MV animals. Hence, a decrease in the rate of 
adenosine triphosphate utilization in muscle fibers 
could lead to a slower rate of fatigue. 
While the current experiments demonstrate that 
short-duration MV improves diaphragmatic fatigue 
resistance, it seems likely that long duration MV (ie, 
weeks to months) will result in a significant decline 
in both diaphragmatic oxidative capacity and fatigue 
resistance. Indeed, experiments investigating the 
physiologic effects of unloading locomotor muscles 
indicate that 15 days of hind-limb suspension results 
in increased fatigability in the soleus muscle.30 Fur- 
ther, work by Anzueto et al7 demonstrated that 11 
days of MV resulted in a decrease in diaphragmatic 
fatigue resistance in baboons. Therefore, it seems 
likely that while relatively short-duration MV does 
not impair diaphragmatic fatigue resistance, long 
duration MV (weeks-to-months) would impair dia- 
phragmatic  endurance. 
Functional Significance of MV-Induced Changes in 
Diaphragmatic Contractile Function 
While the improved fatigue resistance observed in 
diaphragms from MV-treated animals would appear 
to be beneficial against fatigue, it is important to 
consider this in the context of the decrement in total 
specific tension development that occurs following 
18 h of MV (Fig 2). This reduction in total 
diaphragmatic force production in diaphragms 
from MV animals would likely place constraints 
on the diaphragmatic force reserve during periods 
of increased loads.26 Therefore, in clinical situations, 
diaphragms from MV-treated patients may not 
be capable of maintaining ventilatory requirements 
during loading conditions that would occur in 
patients with obstructive airway diseases. In these 
circumstances, diaphragmatic fatigue and 
respiratory failure could occur despite the apparent 
improvement in the rate of diaphragmatic fatigue 
development following MV. 
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